Asia-Pacific Smart Pills Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Asia-Pacific Smart Pills Market is segmented By Product Type (Capsule Endoscopy, Drug Delivery, and Patient Monitoring) By Target Area (Esophagus, Stomach, Small Intestine, and Others) By Disease Indication (Digestive Tract Diseases, Esophageal Diseases, Small Bowel Tumors, and Others) By Country (India, China, Japan, South Korea, Singapore, and Malaysia) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Asia-Pacific Smart Pills Market Overview

The Asia-Pacific Smart Pills Market is expected to grow at a CAGR of 18% during the forecast period 2023-2030.

Smart pills are capsule-sized medical devices that include cameras, sensors, patches, and trackers to aid in targeted drug delivery, efficient diagnostics, and patient monitoring. Once the patient consumes the pill, it helps to assess the patient's health status, which aids in the decision to give drugs. Furthermore, smart pills have been updated in the area of gastrointestinal diagnostics. The inclusion of novel pharmaceuticals, medical devices, and sophisticated technologies is expected to play a vital role in further expanding the market during the forecast period. 

Asia-Pacific Smart Pills Market Summary and Scope

Asia-Pacific Smart Pills Market Drivers

Increasing Research & Development Activities

Many smart pills are being widely researched for their potential application in the diagnosis and treatment of a wide range of chronic and acute disorders. To capitalize on early market prospects, industry participants in emerging countries concentrate largely on producing novel products such as video endoscopy capsules.

The market for smart pills is being driven by the desire for enhanced drug delivery systems with advantages such as optimum utilization of active pharmaceutical ingredients, decreased dosing frequency, reduced adverse/side effects, targeted drug administration, and a safer carrier. Market players such as China's Jinshan Science and Technology (OMOM capsule endoscopy) and South Korea's IntroMedic (MiroCam) are examples of such enterprises that are also employed in research, which drives market growth.

Asia-Pacific Smart Pills Market Opportunities

Utilization in Treating Chronic Patients

People suffering from chronic conditions need a certain dosage of medicine, which are likely to target the patient base for smart pills. Several companies have provided numerous promotional activities such as investments, product launches, and acquisitions. For example, Otsuka (Proteus) released smart chemotherapy tablets in 2019 to enhance the results of cancer patients. In addition, Stanley Black & Decker and Pillo Health released a pill-dispensing robot companion in 2019. As a result, it stimulates market growth.

Increasing Demand for Inpatient Pharmacies

Inpatient pharmacies are projected to dominate the smart pills market due to the growing demand for reduce errors enhance efficiency, and speed. Hospitals provide pre-and post-operative treatments, as well as massive pharmacies to assist these operations. It has been said that smart medicines are becoming increasingly realistic for patients, particularly severe chronic patients, and will save hospitals resources in the long term. As a result, inpatient sources present several opportunities for market growth.

For more details on this report Request for Sample

Asia-Pacific Smart Pills Market Segmentation Analysis

The Asia-Pacific Smart Pills Market is segmented by product type, target area, and disease indication.

The Capsule Endoscopy Segment is Expected to Grow at the Fastest CAGR During the Forecast Period

Capsule endoscopy is the most commonly used application area for smart pills. Capsule endoscopy is an important application area, as smart pills are used to treat related diseases in the GI tract, which include Crohn’s disease, obscure GI bleeding, celiac disease, and small bowel tumors. These pills target the small bowel, which is seen as a golden standard if GI bleeding is suspected.

Conventional scopes that are used for colonoscopy are uncomfortable for the patients. This has given rise to the demand for smart pills. As these pills have revolutionized the diagnosis of gastrointestinal disorders, they are expected to replace conventional endoscopy for certain indications.

In 2019, the National Institutes of Health in the United States had stated that advancements in capsule endoscopy are being done rapidly, and in the near future, doctors will be able to control the movement of the device with an interface application inside the body. Through this technique, they can easily inspect or diagnose any part inside the body. Thus, with the continuous advancements that are being done in the area of endoscopy and with the rising need for proper diagnosis of gastrointestinal disorders, it is expected that the market studied will have rapid growth over the forecast period.

Asia-Pacific Smart Pills Market Regional Insights

The major countries included in the Asia-Pacific smart pills market are India, China, Japan, South Korea, Singapore, Malaysia, Rest of Asia-Pacific.

Japan's market for smart pills is expanding due to mandated healthcare insurance, technical improvements, and an increase in the prevalence of stomach cancer and gastrointestinal illnesses. According to the World Cancer Research Fund International, Japan ranks third among Asian nations in terms of stomach cancer incidence. As a result, a high prevalence of target illnesses, along with increased government assistance, will drive significant market growth.

Asia-Pacific Smart Pills Market Competitive Landscape

The major companies contributing to the Asia-Pacific smart pills market growth include

• Boston Scientific Corporation
• General Electric
• Medtronic
• Microchip Technology Inc
• Novartis AG
• Koninklijke Philips N.V
• Stryker
• FUJIFILM Holdings Corporation
• INTROMEDIC
• PENTAX Medical
• CapsoVision
• Medimetriks Pharmaceuticals, Inc.